Andrew Poklepovic MD

Oncology•Richmond, VA

Breast Cancer, Gastrointestinal Cancer, Melanoma, Sarcoma

Assistant Professor, Internal Medicine, Virginia Commonwealth University, Medical College of Virginia School of Medicine

Join to View Full Profile

VCU Massey Cancer Center1201 East Marshall Street, PO Box 980070McGlothlin Medical education Center 11th floor,Richmond, VA 23298
Phone+1 804-828-7999
Fax+1 804-828-5941

Education & Training

Virginia Commonwealth University Health SystemFellowship, Hematology and Medical Oncology, 2008 - 2011
Virginia Commonwealth University Health SystemResidency, Internal Medicine, 2004 - 2007
University of South Florida College of MedicineClass of 2004

Certifications & Licensure

VA State Medical License 2007 - 2026
American Board of Internal Medicine Medical Oncology

Clinical Trials

Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma Start of enrollment: 2004 Sep 01
Completed
Phase 1
Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Dec 13
Completed
Phase 2
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Start of enrollment: 2009 Oct 28
Completed
Phase 3
Sorafenib and Vorinostat in Treating Patients With Advanced Liver Cancer Start of enrollment: 2010 Aug 10
Completed
Phase 1
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery Start of enrollment: 2011 May 25
ACTIVE_NOT_RECRUITING
PHASE3
Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer Start of enrollment: 2011 Mar 14
Completed
Phase 1
Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers Start of enrollment: 2011 Aug 11
Completed
Phase 1
Randomized RT +/- Lapatinib for Advanced Solid Tumor Cancer Patients Receiving Radiation Therapy for Metastatic Disease Start of enrollment: 2011 Sep 01
Terminated
Early Phase 1
A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma Start of enrollment: 2011 Sep 01
Completed
Phase 3
Pemetrexed Disodium and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors Start of enrollment: 2011 Oct 01
Completed
Phase 1
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer Start of enrollment: 2013 Feb 01
Completed
Phase 2
Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Metastatic Triple-Negative Breast Cancer Start of enrollment: 2013 Oct 02
Completed
Phase 2
A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab Start of enrollment: 2014 May 05
COMPLETED
PHASE1
2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer Start of enrollment: 2016 Jan 28
Terminated
Phase 2
Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer Start of enrollment: 2016 Jul 08
Terminated
Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca Start of enrollment: 2019 May 01
RECRUITING
PHASE1, PHASE2
Join now to see all

Publications & Presentations

PubMed

Risk Factors for COVID-19-Related Hospitalization and Death in Patients With Cancer: The National Cancer Institute COVID-19 in Cancer Patients Study (NCCAPS).
Brian I Rini, Ana F Best, Mel D Bowman, Grace E Mishkin, Andrea M Denicoff
JAMA Oncology. 2025-09-01
The SCD1 inhibitor aramchol interacts with regorafenib to kill GI tumor cellsand.
Laurence Booth, Michael R Booth, Jane L Roberts, Yang Yue, Emily Kinsey
Oncotarget. 2025-08-19
Letter Re: Ossifying fibromyxoid tumours: A case series subtitle: Successful control of a PHF1::TFE3-rearranged metastatic malignant ossifying fibromyxoid tumor using ...
Hyun Lee, Steven Christopher Smith, Joseph Han, Alexander Mink, Andrew Stewart Poklepovic
European Journal of Cancer. 2025-07-25

Press Mentions

VCU Health's Cancer Center Is the Only One in Virginia to Provide TIL Therapy for Advanced MelanomaAugust 18th, 2025
VCU Massey Offers First, Only TIL Therapy for Melanoma in VirginiaAugust 18th, 2025
On TrialApril 21st, 2025
Join now to see all